IJCS | Volume 31, Nº4, Julho / Agosto 2018

432 59. Joy TR, Hegele RA. Narrative review: statin-relatedmyopathy. Ann Intern Med. 2009;150(12):858-68. Doi: 10.7326/0003-4819-150-12-200090616000009 60. Harari M, Dramsdahl E, Shany S, et al. Increased vitamin D serum levels correlate to clinical improvement of rheumatic disease after Dead Sea climatotherapy. Isr Med Assoc J. 2011Apr13;4:212-5. 61. Michalska-KasiczakM,SahebkarA,MikhailidisDP,RyszJ,MuntnerP,Toth PP,,et al. Analysis of vitamin D levels in patients with and without statin- associatedmyalgia–asystematicreviewandmeta-analysisof7studieswith 2420 patients. Int J Cardiol. 2015;178:111-6. Doi:10.1016/j.ijcard.2014.10.118 62. PalamanerSubashShantha G, Ramos J, Thomas-Hemak L, Pancholy SB. Association of vitamin D and incident statin induced myalgia—a retrospective cohort study. PLoS One. 2014;9(2):e88877. Doi:10.1371/ journal.pone.0088877.eCollection2014 63. Morioka TY, Lee AJ, Bertisch S, Buetner A. Vitamin D status modifies the association between statin use and musculoskeletal pain: a population based study. Atherosclerosis. 2015;238(1):77-82. Doi:10.1016/j. atherosclerosis.2014.11.012 64. Wang TJ, Zhang F, Richards JB, KestenbaumB, vanMeurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome- wide association study. Lancet. 2010; 376(9736): 180–8. Doi:10.1016/ S0140-6736(10)60588-0 65. Bracco PA. Randomização mendeliana: um método para estimação de efeitos causais utilizando variantes genéticas como variáveis instrumentais.[Citado em 2016 jan15] Disponível emhttp://hdl.handle . net/10183/158115. 66. Vimaleswaran KS, Cavadino A, Berry DJ, Lifelines Cohort Study Investigators, Jorde R, Lu C, Alves AC, et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomization study. Lancet Diabetes Endocrinol. 2014;2(9):719-29. Doi: 10.1016/S2213-8587(14)70113-5 67. Ye Z, Sharp SJ, Burgess S, Scott RA, Imamura F, InterAct Consortium, et al. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomization study. Lancet Diabetes Endocrinol. 2015;3(1):35-42. Doi: 10.1016/S2213-8587(14)70184-6 68. Manousaki D, Mokry LE, Ross S, Gotzman D, Richards JB. Mendelian Randomization Studies do not Support a Role for Vitamin D in Coronary Artery Disease. Cir Cardiovasc Genet. 2016;9(4):349-56. Doi:10.1161/ CIRCGENETICS.116.001396 69. Hsia J, Heiss G, RenH, AllisonM, DolanNC, Greenland P, et al. Calcium/ vitamin D supplementation and cardiovascular events. Circulation. 2007;115(7):846–54. Doi:10.1161/CIRCULATIONAHA.106.673491 70. Wu L, Sun D. Effects of calcium plus vitamin D supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Human Hypertens. 2017;1(9):547-54. 71. Pitocco D, Crino A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, et al.The effects of calcitriol and nicotinamide on residual pancreatic beta- cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med 2006;23(8):920–3. Doi: 10.1111/j.1484-5491.2006.01 921.X 72. Seida J, Mitri J, Colmers IN, et al. Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J ClinEndocrinolMetab. 2014;99:3551-60. 73. Salehpour A, Shidfar F, Hosseinpanah F, vafaM, RazaghiM, Amiri F. Does vitaminD3 supplementation improve glucose homeostasis in overweight or obesewomen? Adouble-blind, randomized, placebo-controlled clinical trial. Diabet Med. 2013;30(12):1477–81. Doi: 10.1111/dme,12273 74. Ford JA, MacLennan GS, Avenell A, Bolland M, Grey A, Witham M, RECORD Trial Group. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr. 2014;100(3):746-55. Doi:10.3945/ajcn.113.082 602 75. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, et al. Vitamin D and cardiovascular outcomes: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2011;96(7)1931–42. Doi:10.1210/ jc.2011-0398 76. Gotsman I, Shauer A, Zwas DR, Hellman Y, Keren A, Lotan C, et al. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail 2012;14(4):357- 66. Doi:10.1093/eurjhf/hfr175 Jorge et al. Vitamina D e doença cardiovascular Int J Cardiovasc Sci. 2018;31(4)422-432 Artigo de Revisão Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons

RkJQdWJsaXNoZXIy MjM4Mjg=